Tony joined T2 in April of 2019 as the VP and General Manager of International, where he expanded our geographic presence through distribution while growing revenues and placements. Prior to joining T2, Tony was the Chief Commercial Officer for Hemanext, providing executive leadership and leading market development for a pre-revenue company developing a new technology that improved the efficacy of red cell transfusion therapy.
Prior to Hemanext, Tony was the VP of Business Development, Mergers, and Acquisitions for Haemonetics Corporation. In this role, Tony was responsible for all inorganic growth activity, as well as strategy development for entering into new markets. Tony led the acquisition and integration of 13 companies that represented over $300M of the $930M in corporate revenues. In a prior role at Haemonetics, Tony started and led the blood software franchise as its President and General Manager, and grew it to $70M in revenues. He also provided commercial leadership to the Haemonetics Plasma business driving market share from 35% to > 70%.
Tony holds a B.S. in Engineering from Maine Maritime Academy and a Masters in Engineering Administration from George Washington University.